# DOXIL

NDC: 0338-9665
Generic name: doxorubicin hydrochloride
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION, LIPOSOMAL
Routes: INTRAVENOUS
Marketing started: 20240826

FDA application: NDA050718

## Active ingredients

- DOXORUBICIN HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-9665"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-9665
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=917eddf9-1d3f-4abe-8c81-d33b066e5bae